Emanuela Palmerini, Professor at the University of Miami Miller School of Medicine, shared a post on LinkedIn:
“Emerging treatments in bone sarcoma discussed at ESMO2025! The unmet needs require collaborative solutions!
And after only 3 days, positive results were released for chondrosarcoma with INHIBRX-109!
Looking forward first presentation at the CTOS annual meeting!
Thanks to all partners, investigators, patients, and patient advocates!”
More posts featuring ESMO 2025 on OncoDaily.
